NCT04491071

Brief Summary

The aim of this project is to evaluate the impact of pandemic and nonconfinement related to anxiety and eventual immune diseases with several standardized questionnaires : Implant Stability Quotient (ISQ) , Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire -9 (PHQ-9), Post Traumatic Stress Disorder-8 (PTSD-8), and Experiences in Close Relationship Scale (ECRS).

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2020

Shorter than P25 for all trials

Geographic Reach
2 countries

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 29, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

October 22, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 29, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 29, 2021

Completed
Last Updated

April 27, 2023

Status Verified

April 1, 2023

Enrollment Period

11 months

First QC Date

July 27, 2020

Last Update Submit

April 25, 2023

Conditions

Keywords

COVID-19StressEffects on ImmunityAnxiety

Outcome Measures

Primary Outcomes (1)

  • Results of the Generalized Anxiety Disorder (GAD-7)

    test that will evaluate persistent and excessive worry about a number of different things. People with Generalized Anxiety Disorder may anticipate disaster and may be overly concerned about money, health, family, work, or other issues. Individuals with Generalized Anxiety Disorder find it difficult to control their worry. Scored between 0-21: Cut offs: * 0-4 = None * 5-9 = Mild anxiety * 10-14 = Moderate anxiety * 15-21 = Severe anxiety

    5 Minutes

Secondary Outcomes (4)

  • Results of the Mental Health questionnaire

    5 minutes

  • Results of the Patient Health Questionnaire (PHQ-9)

    5 minutes

  • Results of the Post Traumatic Stress Disorder (PTSD-8)

    5 minutes

  • Results of the Experiences in Close Relationship Scale questionnaire (ECR-S)

    5 minutes

Study Arms (1)

Volunteers

volunteers over 18 years of age

Diagnostic Test: Generalized Anxiety Disorder-7 (GAD 7)Diagnostic Test: Background questionnaireDiagnostic Test: Impact of COVID-19 questionnaireDiagnostic Test: Confinement and Communication During the COVID-19 PandemicDiagnostic Test: Mental Health questionnaireDiagnostic Test: Patient Health Questionnaire (PHQ-9)Diagnostic Test: Post Traumatic Stress Disorder questionnaire (PTSD-8)Diagnostic Test: Experiences in Close Relationship Scale questionnaire (ECR-S)

Interventions

test that will evaluate persistent and excessive worry about a number of different things. People with Generalized Anxiety Disorder may anticipate disaster and may be overly concerned about money, health, family, work, or other issues. Individuals with Generalized Anxiety Disorder find it difficult to control their worry.

Volunteers

questionnaire on the living conditions, socio-professional contexts and environmental conditions of the participants

Volunteers

status of the patient with regard to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus)

Volunteers

know the experience of containment and isolation during the pandemic

Volunteers

welfare effect

Volunteers

assess depression during the pandemic

Volunteers

Assessing the trauma of subjects during the pandemic

Volunteers

Measuring social ties and attachment of subjects

Volunteers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Health Volunteers

You may qualify if:

  • Adult volunteer who agreed to answer the questionnaires
  • Age ≥ 18 years old
  • Adult affiliated or having a duty to a social security scheme

You may not qualify if:

  • Children under 18 years old
  • Inability to understand information letter, consent, or to use online questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre Hospitalier Universitaire de Saint-Etienne

Saint-Etienne, 42270, France

Location

Centre de Recherche et d'Innovation Clinique

Glasgow, United Kingdom

Location

MeSH Terms

Conditions

Stress Disorders, TraumaticCOVID-19Anxiety Disorders

Condition Hierarchy (Ancestors)

Trauma and Stressor Related DisordersMental DisordersPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Claude LAMBERT, MD PhD HDR

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 27, 2020

First Posted

July 29, 2020

Study Start

October 22, 2020

Primary Completion

September 29, 2021

Study Completion

September 29, 2021

Last Updated

April 27, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations